| Ytd | -14.35% | |
| 1y | -27.24% |
| Open | 3.48 | Prev Close | 3.56 | Low | 3.46 | High | 3.62 | Mkt Cap | 219.98M |
| Vol | 101.04K | Avg Vol | 2.34M | EPS | -3.06 | P/E | -1.16 | Forward P/E | N/A |
| Beta | 0.39 | Short Ratio | 0.33 | Inst. Own | 11.24% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-13 | 50-d Avg | 5.63 | 200-d Avg | 4.52 | 1yr Est | 0.80 |
INV News
Accelsius, the leader in two-phase, direct-to-chip liquid cooling technology for AI and high-perform
AUSTIN, Texas--(BUSINESS WIRE)--Accelsius, the leader in two-phase, direct-to-chip liquid cooling te
This whale alert can help traders discover the next big trading opportunities. Whales are entities w
The RSI is used to identify oversold stocks in the financial sector, which are good buying opportuni
Innventure, Inc. (NASDAQ: INV), an industrial growth conglomerate, today announced that its Board of
DGXX up 19.5% in pre-market trading after increasing the offering program. EZGO, HPAI, MRAM, NVEC,
Innventure, Inc. (NASDAQ:INV) ("Innventure"), an industrial growth conglomerate that partner
Nektar Therapeutics (NASDAQ: NKTR) rose on positive results for alopecia treatment. Other top gainer
